$DGX
QUEST DIAGNOSTICS INC

2018 Q2 Form 10-Q Financial Statement

#000102207918000163 Filed on July 25, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $1.919B $1.864B
YoY Change 2.95% -2.2%
Cost Of Revenue $1.243B $1.170B
YoY Change 6.24% 1.3%
Gross Profit $676.0M $694.0M
YoY Change -2.59% -7.59%
Gross Profit Margin 35.23% 37.23%
Selling, General & Admin $351.0M $358.0M
YoY Change -1.96% -16.74%
% of Gross Profit 51.92% 51.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $77.00M $66.00M
YoY Change 16.67% 8.2%
% of Gross Profit 11.39% 9.51%
Operating Expenses $351.0M $358.0M
YoY Change -1.96% -16.74%
Operating Profit $305.0M $319.0M
YoY Change -4.39% -24.41%
Interest Expense $43.00M $38.00M
YoY Change 13.16% 8.57%
% of Operating Profit 14.1% 11.91%
Other Income/Expense, Net -$41.00M -$27.00M
YoY Change 51.85% -30.77%
Pretax Income $264.0M $292.0M
YoY Change -9.59% -23.76%
Income Tax $42.00M $94.00M
% Of Pretax Income 15.91% 32.19%
Net Earnings $219.0M $193.0M
YoY Change 13.47% -1.03%
Net Earnings / Revenue 11.41% 10.35%
Basic Earnings Per Share $1.60 $1.40
Diluted Earnings Per Share $1.57 $1.37
COMMON SHARES
Basic Shares Outstanding 136.0M shares 137.0M shares
Diluted Shares Outstanding 139.0M shares 140.0M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $132.0M $314.0M
YoY Change -57.96% 10.95%
Cash & Equivalents $132.0M $314.0M
Short-Term Investments
Other Short-Term Assets $137.0M $156.0M
YoY Change -12.18% -9.3%
Inventory $91.00M $83.00M
Prepaid Expenses
Receivables $1.055B $947.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.415B $1.500B
YoY Change -5.67% -0.66%
LONG-TERM ASSETS
Property, Plant & Equipment $1.168B $1.045B
YoY Change 11.77% 11.53%
Goodwill $6.414B $6.080B
YoY Change 5.49% 1.4%
Intangibles $1.166B $949.0M
YoY Change 22.87% -4.14%
Long-Term Investments $456.0M $451.0M
YoY Change 1.11% -0.44%
Other Assets $128.0M $146.0M
YoY Change -12.33% -34.53%
Total Long-Term Assets $9.332B $8.671B
YoY Change 7.62% 0.84%
TOTAL ASSETS
Total Short-Term Assets $1.415B $1.500B
Total Long-Term Assets $9.332B $8.671B
Total Assets $10.75B $10.17B
YoY Change 5.66% 0.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $957.0M $912.0M
YoY Change 4.93% -17.39%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $305.0M $5.000M
YoY Change 6000.0% -28.57%
Total Short-Term Liabilities $1.262B $917.0M
YoY Change 37.62% -17.46%
LONG-TERM LIABILITIES
Long-Term Debt $3.408B $3.732B
YoY Change -8.68% -2.69%
Other Long-Term Liabilities $738.0M $709.0M
YoY Change 4.09% 36.35%
Total Long-Term Liabilities $738.0M $709.0M
YoY Change 4.09% -83.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.262B $917.0M
Total Long-Term Liabilities $738.0M $709.0M
Total Liabilities $2.000B $1.626B
YoY Change 23.0% -70.25%
SHAREHOLDERS EQUITY
Retained Earnings $7.401B $6.847B
YoY Change 8.09% 7.25%
Common Stock $2.635B $2.567B
YoY Change 2.65% 3.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.756B $4.657B
YoY Change 2.13% 9.19%
Treasury Stock Shares 81.00M shares 80.00M shares
Shareholders Equity $5.223B $4.697B
YoY Change
Total Liabilities & Shareholders Equity $10.75B $10.17B
YoY Change 5.66% 0.61%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $219.0M $193.0M
YoY Change 13.47% -1.03%
Depreciation, Depletion And Amortization $77.00M $66.00M
YoY Change 16.67% 8.2%
Cash From Operating Activities $323.0M $294.0M
YoY Change 9.86% -5.47%
INVESTING ACTIVITIES
Capital Expenditures -$78.00M -$65.00M
YoY Change 20.0% 14.04%
Acquisitions $35.00M $111.0M
YoY Change -68.47%
Other Investing Activities -$48.00M -$105.0M
YoY Change -54.29% -138.32%
Cash From Investing Activities -$126.0M -$170.0M
YoY Change -25.88% -178.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -189.0M -177.0M
YoY Change 6.78% -52.55%
NET CHANGE
Cash From Operating Activities 323.0M 294.0M
Cash From Investing Activities -126.0M -170.0M
Cash From Financing Activities -189.0M -177.0M
Net Change In Cash 8.000M -53.00M
YoY Change -115.09% -134.19%
FREE CASH FLOW
Cash From Operating Activities $323.0M $294.0M
Capital Expenditures -$78.00M -$65.00M
Free Cash Flow $401.0M $359.0M
YoY Change 11.7% -2.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001022079
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
136666678 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
QUEST DIAGNOSTICS INC
CY2017Q2 dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
111000000 USD
dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
112000000 USD
CY2018Q2 dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
35000000 USD
dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
170000000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2017Q2 dgx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
13000000 USD
dgx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
29000000 USD
CY2018Q2 dgx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
5000000 USD
dgx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
13000000 USD
CY2017Q2 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
113000000 USD
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
114000000 USD
CY2018Q2 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
35000000 USD
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
182000000 USD
CY2018Q2 dgx Finite Lived Intangible Assets Estimated Amortization Expense Total
FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal
930000000 USD
CY2018Q2 dgx Income Tax Benefit Associatedwith Changesin Tax Return Accounting Method
IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod
15000000 USD
dgx Income Tax Benefit Associatedwith Changesin Tax Return Accounting Method
IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod
15000000 USD
CY2017Q2 dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
-2000000 USD
dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
-2000000 USD
CY2018Q2 dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
0 USD
dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
-12000000 USD
dgx Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
379000000 USD
dgx Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
419000000 USD
CY2017Q2 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
CY2018Q2 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue
Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue
23000000 USD
dgx Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue
Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue
20000000 USD
dgx Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders
TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
7000000 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1021000000 USD
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
957000000 USD
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
937000000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
924000000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1055000000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-48000000 USD
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2612000000 USD
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2633000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000000 USD
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44000000 USD
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2017Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
369000000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
205000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
389000000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
14000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
25000000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
14000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
26000000 USD
CY2017Q4 us-gaap Assets
Assets
10503000000 USD
CY2018Q2 us-gaap Assets
Assets
10747000000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1306000000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
1415000000 USD
CY2017Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000000 USD
CY2018Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000000 USD
CY2018Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1000000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1000000 USD
CY2017Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2018Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
5000000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137000000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384000000 USD
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137000000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-70000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5000000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
CY2017Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2018Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2018Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217000000 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000000 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
2000000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
201000000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
219000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
415000000 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
1170000000 USD
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.57
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
215000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
394000000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.84
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.321
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.320
us-gaap Cost Of Revenue
CostOfRevenue
2335000000 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
1243000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
2469000000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
1545000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3083000000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
1614000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3226000000 USD
CY2017Q4 us-gaap Debt Current
DebtCurrent
36000000 USD
CY2018Q2 us-gaap Debt Current
DebtCurrent
305000000 USD
CY2017Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4000000000 USD
CY2018Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3900000000 USD
CY2017Q4 us-gaap Deferred Gain Loss On Discontinuation Of Fair Value Hedge
DeferredGainLossOnDiscontinuationOfFairValueHedge
56000000 USD
CY2018Q2 us-gaap Deferred Gain Loss On Discontinuation Of Fair Value Hedge
DeferredGainLossOnDiscontinuationOfFairValueHedge
48000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
79000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
39000000 USD
CY2017Q2 us-gaap Depreciation
Depreciation
48000000 USD
us-gaap Depreciation
Depreciation
93000000 USD
CY2018Q2 us-gaap Depreciation
Depreciation
55000000 USD
us-gaap Depreciation
Depreciation
107000000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
128000000 USD
CY2018Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
151000000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
123000000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
135000000 USD
CY2017Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
62000000 USD
CY2018Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
69000000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.59
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.90
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.53
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.162
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
462000000 USD
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
456000000 USD
CY2017Q2 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
113000000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
114000000 USD
CY2018Q2 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
35000000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
183000000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
534000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
559000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
475000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
88000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
44000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
77000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
78000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
81000000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
87000000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
6000000000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
6335000000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
6414000000 USD
CY2017 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
335000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
79000000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
292000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
538000000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
264000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
493000000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
16000000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
23000000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
94000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172000000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
94000000 USD
CY2017Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
105000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
113000000 USD
CY2018Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
39000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
41000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-93000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-64000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
127000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-37000000 USD
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1653000000 USD
CY2018Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1725000000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1119000000 USD
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1166000000 USD
CY2017Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
0 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1000000 USD
CY2018Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1000000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1000000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
38000000 USD
us-gaap Interest Expense
InterestExpense
75000000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
43000000 USD
us-gaap Interest Expense
InterestExpense
84000000 USD
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-74000000 USD
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-83000000 USD
CY2017Q2 us-gaap Interest Paid
InterestPaid
31000000 USD
us-gaap Interest Paid
InterestPaid
77000000 USD
CY2018Q2 us-gaap Interest Paid
InterestPaid
37000000 USD
us-gaap Interest Paid
InterestPaid
86000000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
95000000 USD
CY2018Q2 us-gaap Inventory Net
InventoryNet
91000000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10503000000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10747000000 USD
CY2017Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2018Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1000000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1057000000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1262000000 USD
CY2017Q4 us-gaap Litigation Reserve
LitigationReserve
2000000 USD
CY2018Q2 us-gaap Litigation Reserve
LitigationReserve
5000000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3748000000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3408000000 USD
CY2017Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
118000000 USD
CY2018Q2 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
123000000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
34000000 USD
CY2018Q2 us-gaap Minority Interest
MinorityInterest
40000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
21000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-343000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-178000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-330000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
490000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
503000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
193000000 USD
us-gaap Net Income Loss
NetIncomeLoss
357000000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
219000000 USD
us-gaap Net Income Loss
NetIncomeLoss
396000000 USD
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
25000000 USD
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
26000000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
193000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
356000000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
219000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
395000000 USD
us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
4000000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-60000000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-41000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-84000000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
319000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
598000000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
305000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
577000000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
136000000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
663000000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
738000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-18000000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2017Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2018Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1000000 USD
CY2017Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1000000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1000000 USD
CY2018Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
3000000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
4000000 USD
CY2017Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
0 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1000000 USD
CY2018Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
0 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
14000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
124000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
129000000 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
20000000 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
28000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
23000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20000000 USD
CY2017Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
111000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
112000000 USD
CY2018Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
165000000 USD
CY2018Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
151000000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
150000000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
137000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1520000000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
97000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
207000000 USD
us-gaap Profit Loss
ProfitLoss
382000000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
233000000 USD
us-gaap Profit Loss
ProfitLoss
422000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1145000000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1168000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
80000000 USD
CY2018Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
76000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
3000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1553000000 USD
CY2017Q2 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2018Q2 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2017Q2 us-gaap Restructuring Charges
RestructuringCharges
3000000 USD
us-gaap Restructuring Charges
RestructuringCharges
6000000 USD
CY2018Q2 us-gaap Restructuring Charges
RestructuringCharges
7000000 USD
us-gaap Restructuring Charges
RestructuringCharges
19000000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7138000000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7401000000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1864000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
3681000000 USD
CY2018Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1919000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
3803000000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
358000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
713000000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
351000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
714000000 USD
CY2017Q2 us-gaap Severance Costs1
SeveranceCosts1
2000000 USD
us-gaap Severance Costs1
SeveranceCosts1
5000000 USD
CY2018Q2 us-gaap Severance Costs1
SeveranceCosts1
4000000 USD
us-gaap Severance Costs1
SeveranceCosts1
15000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
37000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34000000 USD
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1800000 shares
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1300000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13000000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000000 USD
CY2018Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
867000000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4921000000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
5223000000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4660000000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4733000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4955000000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5263000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 USD
CY2016Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
77000000 USD
CY2017Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
80000000 USD
CY2017Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
80000000 USD
CY2018Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
76000000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
3000000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
3000000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
81000000 shares
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
81000000 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4783000000 USD
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
4756000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
300000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000 USD
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140000000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139000000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137000000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136000000 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Background</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services. The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers and accountable care organizations ("ACOs"). The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals. The Company is the world's leading provider of diagnostic information services. The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry and hundreds of M.D.s and Ph.D.s, many of whom are recognized leaders in their fields. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and the Company offers healthcare organizations and clinicians robust information technology solutions.</font></div></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the adoption of the new accounting standard associated with clarifying presentation and classification in the statement of cash flows, certain reclassifications have been made to the prior period financial statements to conform with the current period presentation. In addition, the Company adopted the new revenue recognition accounting standard on a full retrospective basis, which required the Company to restate certain previously reported results. For further details regarding the impact of these new accounting standards, see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Pronouncements</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </font></div></div>

Files In Submission

Name View Source Status
0001022079-18-000163-index-headers.html Edgar Link pending
0001022079-18-000163-index.html Edgar Link pending
0001022079-18-000163.txt Edgar Link pending
0001022079-18-000163-xbrl.zip Edgar Link pending
dgx-20180630.xml Edgar Link completed
dgx-20180630.xsd Edgar Link pending
dgx-20180630_cal.xml Edgar Link unprocessable
dgx-20180630_def.xml Edgar Link unprocessable
dgx-20180630_lab.xml Edgar Link unprocessable
dgx-20180630_pre.xml Edgar Link unprocessable
dgx0630201810-q.htm Edgar Link pending
dgx06302018ex311.htm Edgar Link pending
dgx06302018ex312.htm Edgar Link pending
dgx06302018ex31a.htm Edgar Link pending
dgx06302018ex31b.htm Edgar Link pending
dgx06302018ex321.htm Edgar Link pending
dgx06302018ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending